Clinical trial
α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19 - A Pilot Study
NCT05401773 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19 - A Pilot Study
- Lead sponsor
- Medical University Innsbruck
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 11, 2022
- Completion date
- December 31, 2024
- Enrollment
- 188 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.